Dr. Joanne Pike, CEO of the Alzheimer's Association, talks about the challenges and hopes when it comes to this debilitating ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

An analysis of cerebrospinal fluid has uncovered several proteins likely involved in the development and progression of ...

HUNTSVILLE, Ala ( WHNT) — November is Alzheimer’s Awareness Month. “The disease touches everybody in the patient’s world,” ...

That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...

How do relationships change throughout the journey of Alzheimer’s disease? Changes do occur in many aspects of relationships ...

The last of three walks to end Alzheimer’s is wrapping up this weekend. November is Alzheimer's Awareness Month across the ...

Mike Tomlin sends strong warning about Justin Fields and his role with Steelers after win against Ravens Rhymes with Orange by Hilary Price and Rina Piccolo 'Bomb Cyclone' Set To Explode off US West ...

New recommendations to help healthcare providers explain amyloid therapies to Alzheimer’s patients and their caregivers involve sharing the benefits and risks of the medications.

According to a news release, the JCCR has conducted more than 1,000 clinical trials over 25 years. Global Alzheimer’s ...

Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved ...

USF's Byrd Alzheimer’s Center & Research Institute received the anonymous estate gift with no restrictions, meaning it can be used for research, education or anything else the center prioritizes.